Repare Therapeutics is cutting its headcount by about 25%, with most of the layoffs concentrated in the company’s preclinical team, as part of what the …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Effective control of bovine schistosomiasis will be required to meet disease elimination targets in humans, new research shows.
Share this article A total of 500 new jobs will be created with this investment as per the press release. Credit: JHVEPhoto via www.shutterstock.com. Novo
Mithra, a company dedicated to women’s health, has announced new positive data from preclinical studies on inhibitors of CSF-1R in development, in collaboration with BCI